Multiple ASC-dependent inflammasomes drive differential pro-inflammatory cytokine production in a mouse model of tendinopathy.

IF 3.8 3区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Bioscience Reports Pub Date : 2024-10-29 DOI:10.1042/BSR20241282
Alejandro Peñín-Franch, Laura Hurtado-Navarro, Jose Antonio García-Vidal, Pilar Escolar-Reina, Francesc Medina-Mirapeix, Pablo Pelegrin
{"title":"Multiple ASC-dependent inflammasomes drive differential pro-inflammatory cytokine production in a mouse model of tendinopathy.","authors":"Alejandro Peñín-Franch, Laura Hurtado-Navarro, Jose Antonio García-Vidal, Pilar Escolar-Reina, Francesc Medina-Mirapeix, Pablo Pelegrin","doi":"10.1042/BSR20241282","DOIUrl":null,"url":null,"abstract":"<p><p>Inflammasomes are multiprotein complexes that regulate the bioactive production of IL-1b and IL-18, being implicated in the inflammatory response of different diseases. The inflammasome formed by the cytosolic sensor NLRP3 is highly promiscuous, as it could be activated by different pathogen- and sterile-signals. However, few models have studied the implication of NLRP3 in tissue damage-induced inflammation, particularly the implication of NLRP3 in tendinopathies. Here we aimed to investigate the implication of NLRP3 in a mouse model of tendinopathy by collagenase degradation of the extracellular matrix in the Achilles' mice tendon. We found that NLRP3 was involved in the production of IL-1b and IL-6, but another ASC-dependent inflammasome was required to produce IL-18 during sterile tissue damage. Our study suggests that in the immune response to extracellular matrix degradation different inflammasomes, probably expressed in different cell compartments, were able to differentially control IL-1b and IL-18 production in vivo. These results suggest the potential use of therapies targeting ASC as beneficial in the treatment of tendinopathies.</p>","PeriodicalId":8926,"journal":{"name":"Bioscience Reports","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioscience Reports","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1042/BSR20241282","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Inflammasomes are multiprotein complexes that regulate the bioactive production of IL-1b and IL-18, being implicated in the inflammatory response of different diseases. The inflammasome formed by the cytosolic sensor NLRP3 is highly promiscuous, as it could be activated by different pathogen- and sterile-signals. However, few models have studied the implication of NLRP3 in tissue damage-induced inflammation, particularly the implication of NLRP3 in tendinopathies. Here we aimed to investigate the implication of NLRP3 in a mouse model of tendinopathy by collagenase degradation of the extracellular matrix in the Achilles' mice tendon. We found that NLRP3 was involved in the production of IL-1b and IL-6, but another ASC-dependent inflammasome was required to produce IL-18 during sterile tissue damage. Our study suggests that in the immune response to extracellular matrix degradation different inflammasomes, probably expressed in different cell compartments, were able to differentially control IL-1b and IL-18 production in vivo. These results suggest the potential use of therapies targeting ASC as beneficial in the treatment of tendinopathies.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在小鼠肌腱病模型中,多种依赖于 ASC 的炎性体驱动着不同的促炎细胞因子的产生。
炎症小体是一种多蛋白复合物,可调节 IL-1b 和 IL-18 的生物活性生成,与不同疾病的炎症反应有关。由细胞膜传感器 NLRP3 形成的炎症小体具有很强的混杂性,因为它可以被不同的病原体信号和无菌信号激活。然而,很少有模型研究过 NLRP3 在组织损伤诱导的炎症中的作用,尤其是 NLRP3 在肌腱病中的作用。在这里,我们旨在通过跟腱小鼠细胞外基质的胶原酶降解研究 NLRP3 在小鼠腱鞘炎模型中的作用。我们发现,NLRP3参与了IL-1b和IL-6的产生,但在无菌组织损伤过程中,需要另一个依赖于ASC的炎性体产生IL-18。我们的研究表明,在对细胞外基质降解的免疫反应中,可能在不同细胞区表达的不同炎性体能够以不同方式控制体内IL-1b和IL-18的产生。这些结果表明,针对ASC的疗法有可能用于治疗肌腱病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Bioscience Reports
Bioscience Reports 生物-细胞生物学
CiteScore
8.50
自引率
0.00%
发文量
380
审稿时长
6-12 weeks
期刊介绍: Bioscience Reports provides a home for sound scientific research in all areas of cell biology and molecular life sciences. Since 2012, Bioscience Reports has been fully Open Access and publishes all papers under the liberal CC BY licence, giving the life science community quality research to share and discuss.Content before 2012 is subscription-only, and is accessible via archive purchase. Articles are assessed on soundness, providing a home for valid findings and data. We welcome papers that span disciplines (e.g. chemistry, medicine), including papers describing: -new methodologies -tools and reagents to probe biological questions -mechanistic details -disease mechanisms -metabolic processes and their regulation -structure and function -bioenergetics
期刊最新文献
Overlapping and Distinct Physical and Biological Phenotypes in Pure Frailty and Obese Frailty. Neuroprotective properties of zinc oxide nanoparticles: therapeutic implications for Parkinson's disease. Retraction: miR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma. Retraction: miR-802 participates in the inflammatory process of inflammatory bowel disease by suppressing SOCS5. Expression of Concern: MiR-203a-3p regulates TGF-β1-induced epithelial-mesenchymal transition (EMT) in asthma by regulating Smad3 pathway through SIX1.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1